Disclosure Quest - Search SEC Filings

More options

Type of Offering

Amount To Be Raised

to

Filing Date

to

Type of Security

Industry

CIK Number

Principal Place Of Business

Found 5 results

Name	Type of Offering	Accepted Date
PaxVax, Inc. See All Filings	D/A	2014-08-08 00:00:00 UTC
Amount To Be Raised $35,479,182 Associated Brokers / Dealers N/A CIK Number 0001402296 Filed Document 0001402296-14-000003 Exclusions or Exemptions 506b Accepted Date 2014-08-08 00:00:00 UTC Type of Offering D/A Industry Pharmaceuticals Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Equity
PaxVax Inc See All Filings	D	2014-04-18 00:00:00 UTC
Amount To Be Raised $15,000,000 Associated Brokers / Dealers N/A CIK Number 0001402296 Filed Document 0001402296-14-000002 Exclusions or Exemptions 506b Accepted Date 2014-04-18 00:00:00 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Debt
PaxVax Inc See All Filings	D	2013-12-16 00:00:00 UTC
Amount To Be Raised $25,659,293 Associated Brokers / Dealers N/A CIK Number 0001402296 Filed Document 0001402296-13-000004 Exclusions or Exemptions 506b Accepted Date 2013-12-16 00:00:00 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Equity
PaxVax Inc See All Filings	D	2013-10-30 00:00:00 UTC
Amount To Be Raised $3,000,000 Associated Brokers / Dealers N/A CIK Number 0001402296 Filed Document 0001402296-13-000003 Exclusions or Exemptions 506b Accepted Date 2013-10-30 00:00:00 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Debt
PaxVax Inc See All Filings	D/A	2013-09-30 00:00:00 UTC
Amount To Be Raised $35,106,472 Associated Brokers / Dealers N/A CIK Number 0001402296 Filed Document 0001402296-13-000002 Exclusions or Exemptions 506b Accepted Date 2013-09-30 00:00:00 UTC Type of Offering D/A Industry Pharmaceuticals Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Debt